Legal & General Group Plc - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 1 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2022$3,859,000
+118.8%
56,676
+2.6%
0.00%
+100.0%
Q2 2022$1,764,000
-1.3%
55,231
+7.0%
0.00%0.0%
Q1 2022$1,788,000
+22.9%
51,616
+3.9%
0.00%
Q4 2021$1,455,000
+13.8%
49,698
-0.8%
0.00%
Q3 2021$1,278,000
-5.1%
50,123
+30.4%
0.00%
Q2 2021$1,346,000
-18.0%
38,443
-4.6%
0.00%
-100.0%
Q1 2021$1,642,000
+3.8%
40,297
+10.3%
0.00%0.0%
Q4 2020$1,582,000
-40.3%
36,518
-24.1%
0.00%0.0%
Q3 2020$2,652,000
-13.1%
48,099
-0.5%
0.00%0.0%
Q2 2020$3,051,000
+73.4%
48,323
+40.3%
0.00%0.0%
Q1 2020$1,760,000
-40.2%
34,442
-7.0%
0.00%0.0%
Q4 2019$2,944,000
+101.5%
37,040
+23.0%
0.00%0.0%
Q3 2019$1,461,000
+4.2%
30,120
+13.0%
0.00%0.0%
Q2 2019$1,402,000
+16.4%
26,666
+17.2%
0.00%0.0%
Q1 2019$1,204,000
+34.7%
22,745
+4.4%
0.00%0.0%
Q4 2018$894,000
+30.3%
21,779
+20.6%
0.00%
Q3 2018$686,000
-5.8%
18,065
+12.3%
0.00%
-100.0%
Q2 2018$728,000
-1.5%
16,092
+5.2%
0.00%0.0%
Q1 2018$739,000
+99.2%
15,299
+63.5%
0.00%
Q4 2017$371,000
+24.1%
9,357
-4.3%
0.00%
Q3 2017$299,000
+16.8%
9,775
+4.9%
0.00%
Q2 2017$256,000
+43.8%
9,315
+93.4%
0.00%
Q1 2017$178,000
+187.1%
4,816
+10.1%
0.00%
Q4 2016$62,000
+31.9%
4,376
+106.0%
0.00%
Q3 2016$47,000
-36.5%
2,124
-52.9%
0.00%
Q2 2016$74,0004,5130.00%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q3 2023
NameSharesValueWeighting ↓
Logos Global Management LP 850,000$46,869,0006.00%
Asymmetry Capital Management, L.P. 155,232$8,559,0005.50%
Grace Capital 124,749$6,878,0005.33%
Fernwood Investment Management, LLC 187,477$10,337,0004.88%
Perceptive Advisors 5,800,996$319,867,0004.67%
ArchPoint Investors 217,510$11,993,0003.83%
GREAT POINT PARTNERS LLC 655,676$36,154,0003.25%
Profit Investment Management, LLC 42,196$2,328,0001.44%
Bain Capital Public Equity Management II, LLC 381,868$21,056,0001.39%
Taylor Wealth Management Partners 52,597$2,900,0001.33%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders